Zobrazeno 1 - 10
of 49
pro vyhledávání: '"K. Thalmeier"'
Autor:
K. Thalmeier, Ralf Huss
Publikováno v:
Cytotherapy. 3:245-251
Background CD34 – stem cells are apparently the earliest progenitors of hematopoiesis and mesenchymal tissues. The majority of those progeny rests in the BM as fibroblast-like cells, but can also circulate the peripheral blood. Nevertheless, CD34
Autor:
C. J. Kemp, G. Stingl, C. Caulín, E. G. Jung, H. Tanooka, J. Lassus, E. F. Griffin, Douglas R. Lowy, J. L. Jorcano, J. C. Wang, L. Weber, R. Kato, Paul Janiaud, S. Ohno, A. Schwaaf, R. Gollhausen, N. Sönnichsen, H. Hug, Toshio Kuroki, M. Yaar, J. R. Schlehofer, K. Krasagakis, PE Purkis, Monika M. Gross, H. Heine, H. Mukhtar, J. A. Newton, G. Reisbach, C. Bauer, A. Winter, K. M. Niemi, S. Yamamoto, Bernd L. Sorg, V. A. DeLeo, S. Bruvers, P. Navarro, A. Ootsuyama, G. Tadini, Bert J. Vermeer, D. English, A. B. Bianchi, S. Feil, A. Lehmus, H. Winter, P. T. Strickland, C. Proby, J. M. Foidart, R. Eckert, R. E. Albert, N. E. Fusenig, E. Lee, R. D. Granstein, P. Bums, E. Berti, J. Jürgensmeier, H. Roeser, J. Nährig, A. Anders, F. R. de Gruijl, C. S. Baxter, R. Mailhammer, H. van Weelden, Y. Fujiwara, E. Filvaroff, E. Weber, S. Froschermaier, G. Graf, J. C. Barrett, J. Weiss, H. Weber, B. Hennig, M. Miller, F. Urbach, K. Yamamura, E. Pâques, A. Hülsen, Seymour Garte, B. A. Gilchrest, S. Neill, K. Thalmeier, C. Zechel, Jan P. Vandenbroucke, B. Epe, P. Höfler, B. Przybilla, A. Markey, C. Gilles, C. Bauluz, I. B. Weinstein, U. Van der Piepen, Fokko J. Van Der Woude, T. Jimbo, A. Cano, P. Tomakidi, M. Quintanilla, A. Real, T. Grande, G. T. Bowden, H. Friesel, Y. Mishima, Jan N. Bouwes Bavinck, D. Breitkreutz, Stanley J. Miller, M. Piette, E. Wagner, M. Buček, A. Kopp-Schneider, C. A. Afshari, A. Ranki, M. Garmyn, Margaret L. Kripke, C. Baxter, E. Hecker, Hiroshi Tanooka, F. Harks, E. Lopez-Bran, P. A. Futreal, H. Wei, M. B. Abdel-Naser, A. Diugosz, S. Altmeier, J. Macejewski, Uwe Wollina, J. Römisch, B. Eberlein, E. B. Broecker, Y. Funasaka, M. Glover, M. Haas, S. Gruner, T. Bishop, J. Leers, G. Picht, A. Gilani, W. Diezel, D. S. Silvers, A. Glick, R. Krauß, H. Harris, Anne Østerlind, J. Levy, A. Cerri, E. Danen, K. Schiess, E. Viesel, H. Gröger, B. C. Bastian, K. Hayashibe, K. H. Richter, K. Frenkel, Odilia Popanda, M. Gómez, I. Moll, U. Schleenbecker, M. Ueda, Fritz Anders, H. D. Volk, K. Möller, M. Ichihashi, M. Martín, G. Krauter, S. Krüger-Krasagakes, D. J. Ruiter, J. C. van der Leun, M. Götschl, R. Niedner, Sylvia A. Sedman, T. M. Rünqer, Akira Ootsuyama, Judith P. Johnson, A. Montes, A. G. Ushmorov, G. Bauer, R. Schnapke, S. Kahn, B. Kempkes, C. Garbe, B. Steinbauer, B. K. Armstrong, P. Plein, T. Schneider, C. Missero, B. Schlatterer, M. Schara, P. J. Heenan, M. Stephan, B. A. Burkhart, A. J. P. Klein-Szanto, Eva-B. Bröcker, R. Halaban, S. Grabbe, G. N. P. van Muijen, E. Azizi, D. Schaefer, A. A. Hartmann, C. Ballestin, P. Klein-Bauernschmitt, R. Shukla, G. Kelfkens, M. Nelson, Friedrich Rippmann, M. Kaszkin, S. G. Zubova, Bruce D. Cohen, T. Cody, A. Kricker, V. B. Okulov, P. Fuchs, V. Kinzel, S. Osada, A. Balmain, A. B. Stoler, T. T. Sun, J. Svetek, W. D. Lehmann, F. Larcher, P. Krieg, Jürgen Schweizer, M. Hergenhahn, A. Faissner, G. P. Dotto, C. J. Conti, U. Burcin, L. Hültner, V. Bataille, G. Fürstenberger, EB Lane, A. Smith, D. Jahrens, K. Elgjo, Walter Troll, A. Gandarillas, M. Schön, R. D. Owen, S. Ramón y Cajal, Heinz Walter Thielmann, A. O. Danilov, S. H. Yuspa, J. Cuzick, P. L. Randell, Sylvia Unger, J. A. Boyd, C. Sutter, N. M. Navone, IM Leigh, H. J. Stark, L. A. Annab, R. Gitto, James M. Spencer, C. E. Orfanos, R. M. Lavker, W. Tilgen, R. Albert, H. L. Moses, Eric J. Stanbridge, R. Kosters, Rainer Schmidt, P. Boukamp, E. Schöpf, U. Pascheberg, Yuichi Hashimoto, A. Robledo, F. Marks, J. Sherman, J. Richards, C. E. Klein, Frans H.J. Claas, S. Pečar, Bernard M. Mechler, Doris Rueß, B. Fiebich, Lutz Edler, John T. Schiller, H. Fujiki
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 117:S61-S83
Autor:
Jürgen Podlech, Liane Dreher, Peter Angele, S Maiberger, Sabine Kurz, Hans-Peter Steffens, A Mayer, K Thalmeier, Matthias J. Reddehase
Publikováno v:
Scopus-Elsevier
Bone marrow (BM) failure associated with cytomegalovirus (CMV) infection is a feared complication after clinical BM transplantation. Experiments in long-term BM cultures have indicated that BM stromal cells (BMSC) are targets of productive CMV infect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::638313075ac7d73040ec5897f2900d2f
https://europepmc.org/articles/PMC191681/
https://europepmc.org/articles/PMC191681/
Autor:
F, Bertolini, M, Battaglia, D, Soligo, C, Corsini, C, Curioni, L, Lazzari, P, Pedrazzoli, K, Thalmeier
Publikováno v:
Experimental hematology. 25(4)
Berardi et al. (Science 1995; 267:105) reported recently that combined cytokine stimulation and antimetabolite treatment were able to isolate cells with characteristics of hemopoietic stem cells. Bone marrow (BM) low-density cells were cultured for 1
Autor:
E M, Weissinger, K, Thalmeier, T, Dull, C, Grammer, B, Kempkes, M, Brielmeier, M, Schumm, H J, Kolb
Publikováno v:
International journal of cancer. 68(5)
Chronic myelogenous leukemia is a disease of the pluripotent stem cell that involves the myeloid and, to a varying degree, the lymphoid compartment. We studied the involvement of B cells in chronic myelogenous leukemia at diagnosis and during treatme
Publikováno v:
Cancer research. 56(11)
We recently reported that in stroma-free cultures 11-33% of clonogenic cells derived from a bulk long-term culture [long-term culture-clonogenic cells (LTC-CC)] could be transduced by supernatant exposure or coculture of human CD34+ progenitors with
Publikováno v:
Bone marrow transplantation. 17(3)
Chronic myelogenous leukemia is a clonal proliferative disorder of pluripotent hematopoietic stem cells. Cure may be achieved by myeloablative conditioning treatment and marrow transplantation. In addition, allogeneic marrow can exert a graft-versus-
Constitutive and modulated cytokine expression in two permanent human bone marrow stromal cell lines
Autor:
K, Thalmeier, P, Meissner, G, Reisbach, L, Hültner, B T, Mortensen, A, Brechtel, R A, Oostendorp, P, Dörmer
Publikováno v:
Experimental hematology. 24(1)
We present a detailed analysis of cytokine expression patterns of the two permanent human bone marrow stromal cell lines, L87/4 and L88/5. These cell lines, previously established in our laboratory, are highly radiotolerant without cell detachment an
Publikováno v:
Experimental hematology. 23(14)
Bone marrow and/or peripheral blood of patients with chronic myeloid leukemia (CML) was investigated by the following three parameters: Ph' chromosome, bcr-abl expression in fresh blood and/or bone marrow, and bcr-abl expression in single hematopoiet
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 353
Human erythroid progenitor cells were isolated from peripheral blood of healthy donors and amplified in a suspension culture system using recombinant growth factors (stem cell factor, interleukin-3, granulocyte-macrophage colony-stimulating factor an